AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇨🇮
EMICIZUMAB in Côte d'Ivoire
4 products registered with AIRP — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| HEMLIBRA 105MG/0,7 ML SOLUTION POUR INJECTABLEION FLACON DE 20ML | MD/5O1223-0040 | F. HOFFMANN-LA ROCHE LTD | active | 30 Dec 2028 |
| HEMLIBRA 60MG/0,4ML SOLUTION POUR INJECTABLEION FLACON DE 6ML | MD/5O1223-0039 | F. HOFFMANN-LA ROCHE LTD | active | 29 Dec 2028 |
| HEMLIBRA 150MG SOLUTION POUR INJECTABLEION FLACON DE 1ML | E-2022-0024 | F. HOFFMANN-LA ROCHE LTD | active | 25 May 2027 |
| HEMLIBRA 30MG SOLUTION POUR INJECTABLEION FLACON DE 1ML | E-2022-0023 | F. HOFFMANN-LA ROCHE LTD | active | 25 May 2027 |
EMICIZUMAB — AIRP Registration Details
AIRP (Côte d'Ivoire) has 4 registered products containing EMICIZUMAB, of which 4 are currently active. Data is sourced directly from the official AIRP drug register and refreshed daily.
Track EMICIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.